{"transactions":[{"id":4623207,"issuer":{"id":7266,"kind":"organization","name":"Grace Therapeutics, Inc.","symbol":"GRCE"},"owners":[{"id":69528,"kind":"person","name":"Kottayil George","position":1,"cik":"0001895357","reported_name":"Kottayil George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-21T20:13:11.000Z","date":"2026-09-17","kind":"grant","planned":false,"acquired":true,"shares":12200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"50% of this option vests on the date of grant and the remaining 50% vests in substantially equal monthly installments over a 12-month period, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":12200,"derivative":{"exercise_price":2.13,"expiration_date":"2036-09-16","underlying":"Common Stock","underlying_shares":12200},"source":{"system":"sec-edgar","filing":"0001140361-26-037237","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895357/000114036126037237/form4.xml","form_type":"4"}},{"id":941143,"issuer":{"id":7266,"kind":"organization","name":"Grace Therapeutics, Inc.","symbol":"GRCE"},"owners":[{"id":69528,"kind":"person","name":"Kottayil George","position":1,"cik":"0001895357","reported_name":"Kottayil George","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-12T16:01:36.000Z","date":"2026-01-08","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option vests on the date of grant and the remaining 75% vests in substantially equal monthly installments on the 30th day of each month until September 30, 2026, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":10000,"derivative":{"exercise_price":3.8,"expiration_date":"2036-01-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001140361-26-000968","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895357/000114036126000968/form4.xml","form_type":"4"}},{"id":1151030,"issuer":{"id":7266,"kind":"organization","name":"Grace Therapeutics, Inc.","symbol":"GRCE"},"owners":[{"id":69528,"kind":"person","name":"Kottayil George","position":1,"cik":"0001895357","reported_name":"Kottayil George","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-13T17:21:16.000Z","date":"2025-05-09","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"50% of this option vests on the date of grant and the remaining 50% vests in substantially equal monthly installments on the 30th day of each month until September 30, 2025, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":10000,"derivative":{"exercise_price":2.72,"expiration_date":"2035-05-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001140361-25-018698","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895357/000114036125018698/form4.xml","form_type":"4"}},{"id":1703488,"issuer":{"id":7266,"kind":"organization","name":"Grace Therapeutics, Inc.","symbol":"GRCE"},"owners":[{"id":69528,"kind":"person","name":"Kottayil George","position":1,"cik":"0001895357","reported_name":"Kottayil George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2023-12-20T16:08:23.000Z","date":"2023-12-19","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options granted on 12/19/2023 under the Acasti Pharma Stock Option Plan, which 10,000 shares vest in equal monthly installments over a period of 12 months (provided that 3/12 of the options shall be deemed to have vested upon the date of grant), and 12,500 shares vest in equal quarterly installments over a period of 18 months (Provided that 1/6 of the options shall be deemed to have vested upon the date of grant)."}],"balance_after":22500,"derivative":{"exercise_price":2.125,"expiration_date":"2033-12-19","underlying":"Class A Common Shares","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0000950170-23-071883","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895357/000095017023071883/ownership.xml","form_type":"4"}},{"id":2223189,"issuer":{"id":7266,"kind":"organization","name":"Grace Therapeutics, Inc.","symbol":"GRCE"},"owners":[{"id":69528,"kind":"person","name":"Kottayil George","position":1,"cik":"0001895357","reported_name":"Kottayil George","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, US"}}],"security":"06/22/2022","published_at":"2022-06-23T16:34:16.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Based on conversion of exercise price of C$1.15 into U.S. dollars based on an exchange rate of C$1.00 = US$0.7727 on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options granted on 06/22/2022 under Acasti Pharma Inc.'s Stock Option Plan and become exercisable evenly and on a quarterly basis over 36 months."}],"balance_after":50000,"derivative":{"exercise_price":0.89,"expiration_date":"2032-06-22","underlying":"Class A Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001171843-22-004516","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895357/000117184322004516/ownership.xml","form_type":"4"}}]}